Skip to content

Clinical trials

Phase 2/3 Diabetes Mellitus, Type 1 trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Phase: Phase 2/3 Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20063
20081
20101
20131
20141
20161
20171
20181
20193
20201
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated3
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jaeb Center for Health Research2
Massachusetts General Hospital2
Benjamin U. Nwosu, MD1
Brigham and Women's Hospital1
Dartmouth-Hitchcock Medical Center1
Diabetech1
Eli Lilly and Company1
Emory University1
Florida Atlantic University1
Joslin Diabetes Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 120
Insulin Resistance4
Diabetes Mellitus3
Diabetes Mellitus, Type 23
Atherosclerosis1
Cardiovascular Diseases1
Diabetes Complications1
Diabetic Retinopathy1
Hyperglycemia1
Hypoglycemia1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.